Top Markets
#1 Pons Pons +54.09%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Purr Purr +49.34%
#4 Kinetiq Kinetiq +27.31%
#5 Non-Playable Coin Non-Playable Coin +26.21%
#6 ApeX ApeX +25.57%
#7 Pudgy Penguins Pudgy Penguins +21.07%
#8 OriginTrail OriginTrail +20.36%
#9 Morpho Morpho +20.09%
#10 Grass Grass +19.96%
Coin of the day
Pons Pons
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Rang in Aktien #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Aktienkurs
$2.72
Zuletzt synchronisiert: 2023-10-19
Marktkapitalisierung
$111.47M
Veränderung (1 Tag)
-0.73%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Talaris Therapeutics, Inc. (TALS)

Kategorie

Healthcare
Kursverlauf für Talaris Therapeutics, Inc. (TALS)
Höchster Schlusskurs: $2.72 am 2023-10-01

Niedrigster Schlusskurs: $13.89 am 2021-05-01
Kursverlauf der Aktie von Talaris Therapeutics, Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 124.21%
2022 -91.51%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH